Nuvalent

Nuvalent is one of the...

• Russell 3000.

Nuvalent is a company listed under the stock ticker NUVL (US).

View the org chart displaying its 51 main executives

Most searched biographies at Nuvalent

• James Porter, Chief Executive Officer
• Matthew Shair, Director
• Emily Drabant Conley, Director

Create your alert
to follow the executive moves at Nuvalent.

Nuvalent has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nuvalent

• Nuvalent Investors -
• Nuvalent Investors -
• News | Nuvalent

Social media about Nuvalent

• Nuvalent on Wikipedia, Google News & Yahoo Finance
• Nuvalent on LinkedIn, Twitter & YouTube

Contact by email its executives including James Porter

Call Nuvalent at +1 617...

View the org chart

Register to receive your alert

Report an error